October 5, 2017 – Lucigen Corporation and Illumina Inc. have entered into a License and Knowledge Transfer Agreement (effective September 13, 2017) whereby Lucigen will manufacture and sell the entire Epicentre product portfolio through its worldwide distribution network.

Over the last few months Lucigen has been distributing the entire Epicentre line. This Agreement completes the manufacturing transfer to Lucigen of all Epicentre products. Researchers worldwide can now rely on prompt supply of Epicentre’s high-quality products and continued outstanding technical support from Lucigen.

“We are excited to be able to offer this complete line of genomics products to researchers.  A combined Lucigen and Epicentre product portfolio provides a broad set of unique tools that deliver innovation and ease of use to life scientists,” stated Jeff Williams, President of Lucigen.

“This deal is a win-win for all parties, especially customers,” stated Mark Van Oene, Chief Commercial Officer at Illumina. “Consolidating the sole source and manufacturing of the Epicentre products through Lucigen and its distribution partners simplifies transactions for customers, puts the infrastructure in place to support product line development, and ensures excellence in customer and technical support worldwide.”

Lucigen is proud to bring this expanded portfolio of innovative products to Life Science Professionals.

 

Learn more about Lucigen here. 

 

Sign Up For Our NewsletterWI Biohealth Summit InfoFollow Us on Social